Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
15.77Price to Earnings
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 806.96M | $ 51.16M | 15.77 |
| 3/31/2025 | $ 756.92M | $ 17.18M | 44.06 |
| 12/31/2024 | $ 478.43M | $ -17.93M | 0 |
| 9/30/2024 | $ 609.81M | $ -46.15M | 0 |
| 6/30/2024 | $ 274.83M | $ -53.12M | 0 |
| 3/31/2024 | $ 297.33M | $ -50.24M | 0 |
| 12/31/2023 | $ 188.04M | $ -46.34M | 0 |
| 9/30/2023 | $ 171.56M | $ -39.79M | 0 |
| 6/30/2023 | $ 242.24M | $ -36.9M | 0 |
| 3/31/2023 | $ 233.7M | $ -33.23M | 0 |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, CORMEDIX INC's average P/E has been 29.92.
- The median P/E for CORMEDIX INC during this period was 29.92
- CORMEDIX INC reached its highest P/E over the past 5 years at 44.06.
- The lowest P/E recorded by CORMEDIX INC in the same timeframe 15.77
CORMEDIX INC's P/E vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/E Benchmarks
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for CORMEDIX INC is calculated as follows: Market Cap [ $ 172.87M ] / Net Inc. Cmn. [ $ -21.24M ]
(=) P/E [ 0 ] CRMD - Price to Earnings, Last 5 years
15.77
Minimum
Jun 30, 2025
44.06
Maximum
Mar 31, 2025
29.92
Average
29.92
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.54 with a standard deviation of 14.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.48 |
| average | 22.54 |
| median | 18.89 |
| std | 14 |